Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV

American Journal of Gastroenterology

Volumn 102, Issue 11, 2007, Pages 2536-2540

  Schiano, Thomas D ^a   Kotler, Donald P ^b   Ferran, Elena ^c   Isabel Fiel, M ^a,d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^c LENOX HILL HOSPITAL   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIDANOSINE; LAMIVUDINE PLUS ZIDOVUDINE; NELFINAVIR; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; BLEEDING; CASE REPORT; DIFFERENTIAL DIAGNOSIS; ESOPHAGUS VARICES; HEPATOPORTAL SCLEROSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; SCLEROSIS; STOMACH VARICES;

ADULT; HIV INFECTIONS; HUMANS; HYPERTENSION, PORTAL; LIVER; MALE; MIDDLE AGED; PORTAL SYSTEM; SCLEROSIS;

EID: 35448944283     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01428.x     Document Type: Article

References (36)

1. Bioulac-Sage P, Le Bail B, Bernard P-H, et al. Hepatoportal sclerosis. Semin Liver Dis 1995 15 : 329 39.
2. Reshamwala PA, Leomer DE, Heller T. Nodular regenerative hyperplasia: Not all nodules are created equal. Hepatology 2006 44 : 7 14.
3. Sciot R, Staessen D, Van Damme B, et al. Incomplete septal cirrhosis: Histopathological aspects. Histopathology 1988 13 : 593 603.
4. Nayak NC, Ramalingaswami V. Obliterative portal venopathy of the liver. Associated with so-called idiopathic portal hypertension or tropical splenomegaly. Arch Pathol 1969 87 : 359 69.
5. Ludwig J, Hashimoto E, Obata H, et al. Idiopathic portal hypertension: A histopathological study of 26 Japanese cases. Histopathology 1993 22 : 227 34.
6. Okuda K, Nakashima T, Okudaira M, et al. Liver pathology of idiopathic portal hypertension. Comparison with noncirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study. Liver 1982 2 : 176 92.
7. Hillaire S, Bonte E, Denninger M-H, et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: A re-evaluation in 28 patients. Gut 2002 51 : 275 80.
8. Okudaira M, Ohbu M, Okuda K. Idiopathic portal hypertension and its pathology. Semin Liver Dis 2002 22 : 59 72.
9. Ibarrola C, Colina F. Clinicopathological features of nine cases of non-cirrhotic portal hypertension: Current definitions and criteria are inadequate. Histopathology 2003 42 : 251 64.
10. Fiel MI, Thung SN, Hytiroglou P, et al. Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis. Am J Surg Pathol 2007 31 : 607 14.
11. Krasinskas AM, Eghtesad B, Kamath PS, et al. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl 2005 11 : 627 34.
12. Maida I, Núñez M, Ríos MJ, et al. Severe liver disease associated with prolonged exposure to antiretroviral drugs. JAIDS 2006 42 : 177 82.
13. Podevin P, Spiridon G, Terris B, et al. Nodular regenerative hyperplasia of the liver after IL-2 therapy in an HIV-infected patient. AIDS 2006 20 : 313 5.
14. Carr A, Morey A, Mallon P, et al. Fatal portal hypertension, liver failure and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia. Lancet 2001 357 : 1412 4.
15. Dhiman RK, Chawla Y, Vashista RK, et al. Non-cirrhotic portal fibrosis (idiopathic portal hypertension): Experience with 151 patients and a review of the literature. J Gastroenterol Hepatol 2002 17 : 6 16.
16. Sarin SK, Kapoor D. Non-cirrhotic portal fibrosis: Current concepts and management. J Gastroenterol Hepatol 2002 17 : 526 34.
17. Wanless IR, Godwin TA, Allen F, et al. Nodular regenerative hyperplasia of the liver in hematologic disorders: A possible response to obliterative portal venopathy. Medicine 1980 59 : 367 79.
18. Al-Mukhaizeem KA, Rosenberg A, Sherker AH. Nodular regenerative hyperplasia of the liver: An underrecognized cause of portal hypertension in hematological disorders. Am J Hematol 2004 75 : 225 30.
19. Abraham S, Begum S, Isenberg D. Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 2004 63 : 123 29.
20. Shastri S, Dubinsky MC, Poordad F, et al. Early nodular hyperplasia of the liver occurring with inflammatory bowel diseases in association with thioguanine therapy. Arch Pathol Lab Med 2004 128 : 49 53.
21. Crawford AR, Lin X-Z, Crawford JM. The normal adult human liver biopsy: A quantitative reference standard. Hepatology 1998 28 : 323 31.
22. Nakanuma Y, Hoso M, Sasaki M, et al. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology 1996 28 : 195 204.
23. Loinaz C, Colina F, Musella M, et al. Orthotopic liver transplantation in 4 patients with portal hypertension and non-cirrhotic nodular liver. Hepato-Gastroenterology 1998 45 : 1787 94.
24. Geller SA, Dubinsky MC, Poordad FF, et al. Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease. Am J Surg Pathol 2004 28 : 1204 11.
25. De Bruyne R, Portmann B, Samyn M, et al. Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia. J Hepatol 2006 44 : 407 10.
26. Katzka DA, Saul SH, Jorkasky D, et al. Azathioprine and hepatic venocclusive disease in renal transplant patients. Gastroenterology 1986 90 : 446 54.
27. Kontorinis N, Dieterich DT. Toxicity of non-nucleoside analogue reverse transcriptase inhibitors. Semin Liv Dis 2003 23 : 173 80.
28. Balthazar EJ, Gollapudi P. Septic thrombophlebitis of the mesenteric and portal veins: CT imaging. J Comput Assist Tomogr 2000 24 : 755 60.
29. Chalasani N, Wilcox CM. Gastrointestinal hemorrhage in patients with AIDS. Aids Patient Care STDS 1999 13 : 343 6.
30. Macias J, Castellano V, Merchante N, et al. Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: Harmful impact of nevirapine. AIDS 2004 18 : 767 74.
31. Martin-Carbonero L, Soriano V. Interplay between hepatitis C, liver steatosis, and anti-retroviral therapy in HIV-infected patients. AIDS 2005 19 : 621 3.
32. Klein SK, Slim EJ, de Kruif MD, et al. Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med 2005 63 : 129 36.
33. Sudano I, Spieker LE, Noll G, et al. Cardiovascular disease in HIV infection. Am Heart J 2006 151 : 1147 55.
34. Quereda C, Moreno S, Moreno L, et al. The role of liver biopsy in the management of chronic hepatitis C in patients infected with the human immunodeficiency virus. Hum Pathol 2004 35 : 1083 7.
35. Marine-Barjoan E, Saint-Paul MC, Pradier C, et al. Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients. AIDS 2004 18 : 2163 70.
36. Brau N, Salvatore M, Rios-Bedova CF, et al. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol 2006 44 : 47 55.